Azilsartan prevents central modulation of BDNF and PPARγ in Alzheimer’s pathology through amyloidogenic and inflammatory pathways: experimental and computational evidence
Fields of Study & Subjects
Renin-Angiotensin System Studies
Alzheimer's disease research and treatments
Neurological Disease Mechanisms and Treatments
Publication details
- Journal / source
- Inflammopharmacology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 34
- Issue
- 3
- Pages
- 2003–2025
- Publication date
- 20 February 2026
- Language
- EN